In the BioHarmony Drug Report Database

"Preview" Icon

Azatadine

Optimine (azatadine) is a small molecule pharmaceutical. Azatadine was first approved as Optimine on 1982-01-01. It is used to treat allergic rhinitis perennial, allergic rhinitis seasonal, ear diseases, respiration disorders, and urticaria in the USA.

 

Trade Name

 

Optimine
 

Common Name

 

azatadine
 

ChEMBL ID

 

CHEMBL946
 

Indication

 

allergic rhinitis perennial, allergic rhinitis seasonal, ear diseases, respiration disorders, urticaria
 

Drug Class

 

Tricyclic histaminic-H1 receptor antagonists, loratadine derivatives

Image (chem structure or protein)

Azatadine structure rendering